Want to see TSE:XLY full AI Analyst Report?
XLY Stock Chart & Stats
C$0.14
>-C$0.01(-10.00%)
At close: 4:00 PM EST
C$0.14
>-C$0.01(-10.00%)
Day’s Range― - ―
52-Week RangeC$0.11 - C$0.22
Previous CloseN/A
Volume80.76K
Average Volume (3M)979.68K
Market Cap
C$257.70M
Enterprise ValueC$222.24
Total Cash (Recent Filing)C$43.06M
Total Debt (Recent Filing)C$55.78M
Price to Earnings (P/E)7.5
Beta0.78
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,431,677,500
10 Day Avg. Volume1,296,089
30 Day Avg. Volume979,678
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.25Price Target Upside78.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$162.60M
Bulls Say, Bears Say
Bulls Say
Diversified Product And Distribution ModelAuxly’s core business sells finished, branded cannabis products into provincially run distribution systems across multiple formats. That diversified product mix and reliance on established provincial channels support durable revenue streams, shelf presence and bargaining stability versus single-product exposure.
Sustained Profitability TurnaroundThe company moved from multi-year losses to sustained positive operating and net profit, indicating structural improvement in unit economics. Durable margins enable reinvestment in brand, R&D and distribution, reducing dependence on capital raises and improving long-term viability.
Material Improvement In Cash Generation And LeverageConsistent positive operating and free cash flow alongside lower leverage enhances financial flexibility. Stronger cash generation supports capex, working capital and marketing without frequent external funding, making the business more resilient to regulatory or demand swings.
Bears Say
Recent Margin CompressionMargin gains have moderated in the most recent TTM period, indicating pricing, mix, or cost pressures may be re-emerging. If sustained, this could blunt the earnings recovery, limit reinvestment capacity and raise sensitivity to input-cost or competitive shifts over the medium term.
Short Track Record Of Cash StrengthAlthough cash generation is now positive, it’s a recent development following years of negative cash flow. The short runway of consistent free cash flow increases execution risk: a reversal could force reliance on external financing, hampering strategic initiatives and growth.
Residual Refinancing Sensitivity From Prior LeverageBalance sheet metrics have improved, but the company emerged from a period of elevated leverage. Remaining sensitivity to refinancing or market access means adverse macro or sector shocks could quickly constrain liquidity and investment, limiting long-term strategic optionality.
Auxly Cannabis Group News
XLY FAQ
What was Auxly Cannabis Group Inc’s price range in the past 12 months?
Auxly Cannabis Group Inc lowest stock price was C$0.11 and its highest was C$0.21 in the past 12 months.
What is Auxly Cannabis Group Inc’s market cap?
Auxly Cannabis Group Inc’s market cap is C$257.70M.
When is Auxly Cannabis Group Inc’s upcoming earnings report date?
Auxly Cannabis Group Inc’s upcoming earnings report date is Aug 17, 2026 which is in 27 days.
How were Auxly Cannabis Group Inc’s earnings last quarter?
Auxly Cannabis Group Inc released its earnings results on May 14, 2026. The company reported C$0 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Auxly Cannabis Group Inc overvalued?
According to Wall Street analysts Auxly Cannabis Group Inc’s price is currently Undervalued.
Does Auxly Cannabis Group Inc pay dividends?
Auxly Cannabis Group Inc does not currently pay dividends.
What is Auxly Cannabis Group Inc’s EPS estimate?
Auxly Cannabis Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Auxly Cannabis Group Inc have?
Auxly Cannabis Group Inc has 1,431,677,500 shares outstanding.
What happened to Auxly Cannabis Group Inc’s price movement after its last earnings report?
Auxly Cannabis Group Inc reported an EPS of C$0 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Auxly Cannabis Group Inc?
Currently, no hedge funds are holding shares in TSE:XLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auxly Cannabis Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.25 (78.57% Upside)
C$0.25 (78.57% Upside)
Insider Transactions
Bought Shares
Worth C$215.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
300.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.92%
Trailing 12-Months
Company Description
Auxly Cannabis Group Inc
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis formats under its distinct brands—KOLAB PROJECT, Dosecann, BACK FORTY, and Foray—including vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. Originally incorporated in 1987, the company was known as Cannabis Wheaton Income Corp. before officially changing its name to Auxly Cannabis Group Inc. in June 2018. It is headquartered in Toronto, Canada.
XLY Stock 12 Month Forecast
Average Price Target
C$0.25
▲(78.57% Upside)







